PITFALL OF UNPROVEN THERAPIES

被引:0
|
作者
CARDWELL, MA
机构
关键词
D O I
10.1111/j.1746-1561.1979.tb08114.x
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
引用
收藏
页码:421 / 421
页数:1
相关论文
共 50 条
  • [41] Physician Responsibility to Discuss Palliative Unproven Therapies With Out-of-Option Patients
    Kawam, Omar
    Tilburt, Jon C.
    Master, Zubin
    AMERICAN JOURNAL OF BIOETHICS, 2021, 21 (12): : 31 - 33
  • [42] Patients' Attitudes to Unproven Therapies in Treating COVID-19 Merit Evaluation
    Li, Hong-Tian
    Cheng, Zhi-Hao
    Huang, Yong-Ying
    Lv, Xi-Lin
    Zhou, Yu-Bo
    Dong, Erdan
    Liu, Jian-Meng
    INNOVATION, 2020, 1 (02):
  • [43] Reassessing direct-to-consumer portrayals of unproven stem cell therapies: is it getting better?
    Ogbogu, Ubaka
    Rachul, Christen
    Caulfield, Timothy
    REGENERATIVE MEDICINE, 2013, 8 (03) : 361 - 369
  • [44] The European Court of Human Rights' Ruling on Unproven Stem Cell Therapies: A Missed Opportunity?
    Rial-Sebbag, Emmanuelle
    Blasimme, Alessandro
    STEM CELLS AND DEVELOPMENT, 2014, 23 : 39 - 43
  • [45] COVID-19 EARLY AFTER RENAL TRANSPLANTATION: LIMITATIONS AND HAZARDS OF UNPROVEN THERAPIES
    Vistoli, Fabio
    Falcone, Marco
    Cacace, Concetta
    Perrone, Vittorio Grazio
    Tiseo, Giusy
    Kauffmann, Emanuele Federico
    Morea, Alessandra
    Napoli, Niccolo
    Arzilli, Chiara
    Corradi, Francesco
    Bianco, Irene
    Mazzoni, Alessandro
    Forfori, Francesco
    Menichetti, Francesco
    Boggi, Ugo
    TRANSPLANT INTERNATIONAL, 2021, 34 : 367 - 367
  • [46] Erratum to: Untested, unproven, and unethical: the promotion and provision of autologous stem cell therapies in Australia
    Alison K. McLean
    Cameron Stewart
    Ian Kerridge
    Stem Cell Research & Therapy, 7
  • [47] Interaction between unproven cellular therapies and global medicinal product approval regulatory frameworks
    Nichols, Karen
    Janssen, William
    Wall, Dominic
    Cuende, Natividad
    Griffin, Deborah
    CYTOTHERAPY, 2016, 18 (01) : 127 - 137
  • [48] Positioning a Scientific Community on Unproven Cellular Therapies: The 2015 International Society for Cellular Therapy Perspective
    Dominici, Massimo
    Nichols, Karen
    Srivastava, Alok
    Weiss, Daniel J.
    Eldridge, Paul
    Cuende, Natividad
    Deans, Robert J.
    Rasko, John E. J.
    Levine, Aaron D.
    Turner, Leigh
    Griffin, Deborah L.
    O'Donnell, Lynn
    Forte, Miguel
    Mason, Chris
    Wagena, Edwin
    Janssen, William
    Nordon, Robert
    Wall, Dominic
    Ho, Hong-Nerng
    Ruiz, Milton A.
    Wilton, Steve
    Horwitz, Edwin M.
    Gunter, Kurt C.
    CYTOTHERAPY, 2015, 17 (12) : 1663 - 1666
  • [49] Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies
    Caplan, Arthur L.
    Waldstreicher, Joanne
    Childers, Karla
    Maree, Aran
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (11): : 5622 - 5623
  • [50] UNPROVEN INTEREST
    Tricomi, Antonio
    PONTE, 2016, 72 (06) : 125 - 127